Citations 1-10 of 147 total displayed.

News

Drug maker’s PR firm is force behind blood clot awareness campaign

Ray Moynihan

BMJ 2008;336:1460, doi: 10.1136/bmj.a502, (Published 28 June 2008)

[Extract] [Full text] [PDF]  

Feature

Key opinion leaders: independent experts or drug representatives in disguise?

Ray Moynihan

BMJ 2008;336:1402, doi: 10.1136/bmj.39575.675787.651, (Published 21 June 2008)

[Extract] [Full text] [PDF]  

Head to Head

Should the drug industry work with key opinion leaders? Yes

Charlie Buckwell

BMJ 2008;336:1404, doi: 10.1136/bmj.39541.702870.59, (Published 21 June 2008)

[Extract] [Full text] [PDF]  

Head to Head

Should the drug industry work with key opinion leaders? No

Giovanni A Fava

BMJ 2008;336:1405, doi: 10.1136/bmj.39541.731493.59, (Published 21 June 2008)

[Extract] [Full text] [PDF]  

News

Review launched after Harvard psychiatrist failed to disclose industry funding

Jeanne Lenzer

BMJ 2008;336:1327, doi: 10.1136/bmj.39609.364688.DB, (Published 14 June 2008)

[Extract] [Full text] [PDF]  

Feature

Product placement in the waiting room

Leo Hickman

BMJ 2008;336:1274, doi: 10.1136/bmj.39589.491030.BD, (Published 7 June 2008)

[Extract] [Full text] [PDF]  

News

Merck to pay $58m in settlement over rofecoxib advertising

Fred Charatan

BMJ 2008;336:1208, doi: 10.1136/bmj.39591.705231.DB, (Published 31 May 2008)

[Extract] [Full text] [PDF]  

News

MEPs shun cancer advocacy group because of industry funding

Ned Stafford

BMJ 2008;336:980, doi: 10.1136/bmj.39566.553889.DB, (Published 3 May 2008)

[Extract] [Full text] [PDF]  

News

Academic freedom is at risk in dispute over Gardasil, lecturers say

Melissa Sweet

BMJ 2008;336:741, doi: 10.1136/bmj.39535.642025.DB, (Published 5 April 2008)

[Extract] [Full text] [PDF]  

News

Australian drug industry gives details of money spent courting doctors

Bob Burton

BMJ 2008;336:742, doi: 10.1136/bmj.39535.488299.DB, (Published 5 April 2008)

[Extract] [Full text] [PDF]